LETTER TO THE EDITOR
Strategies toward virus and prion safe human platelet lysates
Johannes Blümel,
Corresponding Author
Johannes Blümel
Division Virology, Paul-Ehrlich-Institut, Langen, Germany
Search for more papers by this author Astrid Schwantes,
Astrid Schwantes
Division Virology, Paul-Ehrlich-Institut, Langen, Germany
Search for more papers by this author Sally A. Baylis,
Sally A. Baylis
Division Virology, Paul-Ehrlich-Institut, Langen, Germany
Search for more papers by this author Albert Stühler,
Albert Stühler
Division Virology, Paul-Ehrlich-Institut, Langen, Germany
Search for more papers by this author
Johannes Blümel,
Corresponding Author
Johannes Blümel
Division Virology, Paul-Ehrlich-Institut, Langen, Germany
Search for more papers by this author Astrid Schwantes,
Astrid Schwantes
Division Virology, Paul-Ehrlich-Institut, Langen, Germany
Search for more papers by this author Sally A. Baylis,
Sally A. Baylis
Division Virology, Paul-Ehrlich-Institut, Langen, Germany
Search for more papers by this author Albert Stühler,
Albert Stühler
Division Virology, Paul-Ehrlich-Institut, Langen, Germany
Search for more papers by this author
First published: 02 January 2020
No abstract is available for this article.
CONFLICT OF INTEREST
All authors contributed equally to this work.
REFERENCES
- 1Bieback K, Fernandez-Muñoz B, Pati S, et al. Gaps in the knowledge of human platelet lysate as a cell culture supplement for cell therapy: a joint publication from the AABB and the International Society for Cell & Gene Therapy. Transfusion. 2019; 59: 3448–60.
- 2Allain JP, Owusu-Ofori AK, Assennato SM, et al. Effect of Plasmodium inactivation in whole blood on the incidence of blood transfusion-transmitted malaria in endemic regions: the African Investigation of the Mirasol System (AIMS) randomised controlled trial. Lancet 2016; 387: 1753-61.
- 3Hauser L, Roque-Afonso AM, Beylouné A, et al. Hepatitis E transmission by transfusion of Intercept blood system-treated plasma. Blood 2014; 123: 796-7.
- 4Viau S, Eap S, Chabrand L, et al. Viral inactivation of human platelet lysate by gamma irradiation preserves its optimal efficiency in the expansion of human bone marrow mesenchymal stromal cells. Transfusion 2019; 59: 1069-79.
- 5Schallmoser K, Henschler R, Gabriel C, et al. Production and quality requirements of human platelet lysate: a position statement from the working party on cellular therapies of the International Society of Blood Transfusion. Trends Biotechnol. 2019; 38: 13–23.
